INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2011
Total net assets |
£97.7m |
NAV per share |
174.4p |
Share price |
150.5p |
Total value of unquoted investments |
£22.8m |
Total number of portfolio companies |
62 |
Cash |
(1)% NAV |
Cash committed and reserved to unquoted investments |
9% NAV |
Portfolio companies with < 1 year of cash |
11% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
5.53 |
Teva |
5.46 |
Cadent |
5.39 |
Gilead Sciences |
5.24 |
Insulet |
4.42 |
Shire |
4.30 |
Celgene |
3.73 |
Micromet |
3.70 |
Actelion |
3.53 |
Pharmasset |
3.09 |
|
----------- |
Total |
44.39 |
Geographical Allocation |
% |
United States |
72 |
Europe |
22 |
Israel |
5 |
Australia |
2 |
Cash |
(1) |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
78 |
Unquoted |
23 |
Cash |
(1) |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
24 AUGUST 2011